CYP7A1 and coronary artery disorder: Regarding Nr1h4, the farnesoid X receptor that counteracts the expression of Cyp7a1, avoiding excess of BA synthesis, only a minimal but statistically significant decrease was observed in NOD1 KO livers under HFD vs. CHD.